Evogene Ltd

EVGN

Company Profile

  • Business description

    Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

  • Contact

    13 Gad Feinstein Street
    Park Rehovot
    Ness Ziona
    Rehovot7638517
    ISR

    T: +972 89311900

    E: [email protected]

    https://www.evogene.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    52

Stocks News & Analysis

stocks

ASX property share lifts guidance despite sector headwinds

Aussie property manager lifts earnings expectations despite interest rate uncertainty.
stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,945.2066.700.75%
CAC 408,207.8934.780.43%
DAX 4025,177.807.09-0.03%
Dow JONES (US)50,662.00200.320.40%
FTSE 10010,505.0113.620.13%
HKSE25,328.23271.22-1.06%
NASDAQ26,621.9334.26-0.13%
Nikkei 22564,999.413.320.01%
NZX 50 Index13,227.81158.071.21%
S&P 5007,514.274.85-0.06%
S&P/ASX 2008,717.7065.500.76%
SSE Composite Index4,093.7351.65-1.25%

Market Movers